Literature DB >> 1505654

Association of a polymorphism in the Apo AI gene promoter with hyperalphalipoproteinemia.

F Pagani1, G A Giudici, F E Baralle, C Vergani.   

Abstract

The distribution of a polymorphism due to an Adenine to Guanine transition in the ApoAI gene has been studied in 136 women and 108 men, through amplification of the promoter region of the gene and allele-specific oligonucleotide hybridization. The allelic frequencies for the A allele were 0.10, 0.14 and 0.27 in women and 0.08, 0.17 and 0.14 in men for the lowest decile, intermediate group and the highest decile of HDL-cholesterol levels, respectively. Statistical analysis showed that the A allele was associated with high HDL-cholesterol levels in women, but not in men.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505654     DOI: 10.1007/bf00145350

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Fine structure genetic analysis of a beta-globin promoter.

Authors:  R M Myers; K Tilly; T Maniatis
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

Review 2.  Regulation of inducible and tissue-specific gene expression.

Authors:  T Maniatis; S Goodbourn; J A Fischer
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

Review 3.  Genetic factors affecting blood lipoproteins: the candidate gene approach.

Authors:  A J Lusis
Journal:  J Lipid Res       Date:  1988-04       Impact factor: 5.922

4.  Three regions upstream from the cap site are required for efficient and accurate transcription of the rabbit beta-globin gene in mouse 3T6 cells.

Authors:  P Dierks; A van Ooyen; M D Cochran; C Dobkin; J Reiser; C Weissmann
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

5.  Transcriptional control signals of a eukaryotic protein-coding gene.

Authors:  S L McKnight; R Kingsbury
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

6.  Dual tissue-specific expression of apo-AII is directed by an upstream enhancer.

Authors:  C S Shelley; F E Baralle
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

7.  High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.

Authors:  R D Abbott; P W Wilson; W B Kannel; W P Castelli
Journal:  Arteriosclerosis       Date:  1988 May-Jun

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types.

Authors:  K N Sastry; U Seedorf; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

10.  Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes.

Authors:  S K Karathanasis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  2 in total

1.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.

Authors:  Robert Block; James Corsetti; Ilan Goldenberg; Gabriel Vorobiof; Scott McNitt; Daniel Ryan; Wojciech Zareba; Arthur J Moss
Journal:  Heart Int       Date:  2009-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.